{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-030456","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2026-09-15T20:44:10+00:00","discovered_at":"2026-09-15T20:45:40.512261+00:00","generated_at":"2026-09-15T20:45:49.416037+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pulse Biosciences signs new $85M ATM equity program with Mizuho, ends TD Cowen ATM","bullets":["New equity distribution agreement with Mizuho allows up to $85M in common stock sales; commission up to 3.0%.","As of Sep 14, 2026, 1.38M shares sold under prior Aug 2026 Mizuho ATM, raising ~$68.8M of $75M limit.","Terminated TD Cowen distribution agreement with ~$1.0M unsold; effective Sep 14, 2026.","Sales via at-the-market offerings on Nasdaq under S-3 shelf (File 333-293596) effective Feb 27, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-030456","json":"https://secwatch.observer/filing/0001437749-26-030456.json","markdown":"https://secwatch.observer/filing/0001437749-26-030456.md","text":"https://secwatch.observer/filing/0001437749-26-030456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926030456/0001437749-26-030456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926030456/plse20260914_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-15T20:45:49.416037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}